Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 16,434.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 16,434.43% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,816.02% |
Diginex Limited Ordinary Shares (DGNX) | 1,212.68% |
FiEE (FIEE) | 1,092.66% |
Oncology Institute (TOI) | 1,007.84% |
Hycroft Mining (HYMC) | 984.96% |
Palvella Therapeutics (PVLA) | 839.45% |
XMax (XWIN) | 819.7% |
Abits (ABTS) | 796.55% |
Relmada Therapeutics (RLMD) | 765.46% |
DeFi Development (DFDV) | 733.7% |
Cidara Therapeutics (CDTX) | 714.64% |
Celcuity LLC (CELC) | 665.05% |
Nanobiotix (NBTX) | 635.69% |
Terns Pharmaceuticals (TERN) | 620.57% |
Lizhi (SOGP) | 604.59% |
Newegg Commerce (NEGG) | 597.13% |
Sandisk (SNDK) | 587.54% |
AXT (AXTI) | 585.59% |
TMC the metals (TMC) | 576.32% |
Charming Medical Limited Class A Ordinary Shares (MCTA) | 539.54% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 537.07% |
DBV Technologies (DBVT) | 516.11% |
Almonty Industries Inc Common Shares (ALM) | 513.89% |
